SCHEMBL22689686

SCHEMBL22689686

N[C@@H](Cc1ccc(NC(=O)CI)cc1)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 3/20 0.56
SLC1A3 P43003 2/20 0.55
SLC1A2 P43004 2/20 0.55
SLC1A1 P43005 2/20 0.55
PTGS1 P23219 3/20 0.54
ALPI P09923 1/20 0.54
PKM P14618 1/20 0.54
XIAP P98170 1/20 0.54
ITGB3 P05106 1/20 0.49
ITGAV P06756 1/20 0.49
ITGA2B P08514 1/20 0.49
HIF1A Q16665 5/20 0.49
LTA4H P09960 4/20 0.49
CYP3A4 P08684 3/20 0.49
ALOX15 P16050 3/20 0.49
ALDH1A1 P00352 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
TDP1 Q9NUW8 2/20 0.49
KDM4E B2RXH2 2/20 0.49
ABCB11 O95342 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22689687 1.00 SLC7A5 (0.56) SLC7A5SLC1A3SLC1A2SLC1A1PTGS1
SCHEMBL22689712 0.88 LTA4H (0.54) SLC7A5SLC1A3SLC1A2SLC1A1PTGS1
SCHEMBL22689711 0.88 LTA4H (0.54) SLC7A5SLC1A3SLC1A2SLC1A1PTGS1
SCHEMBL22689753 0.85 LTA4H (0.51) SLC7A5SLC1A3SLC1A2SLC1A1PTGS1
SCHEMBL22689755 0.85 LTA4H (0.51) SLC7A5SLC1A3SLC1A2SLC1A1PTGS1
SCHEMBL4943107 0.85 SLC7A5 (0.61) SLC7A5SLC1A3SLC1A2SLC1A1PTGS1
SCHEMBL3059437 0.85 SLC7A5 (0.61) SLC7A5SLC1A3SLC1A2SLC1A1PTGS1
SCHEMBL30037334 0.85 SLC7A5 (0.61) SLC7A5SLC1A3SLC1A2SLC1A1PTGS1
SCHEMBL12835439 0.84 ALDH1A1 (0.56) SLC7A5SLC1A3SLC1A2SLC1A1PTGS1
SCHEMBL16860980 0.84 SLC7A5 (0.56) SLC7A5SLC1A3SLC1A2SLC1A1PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12460317-B2 Genetically encoded, phage-displayed cyclic peptide library and methods of making the same THE TEXAS A&M UNIVERSITY SYSTEM (US) 2025-11-04 US disclosed
US-20230139680-A1 A GENETICALLY ENCODED, PHAGE-DISPLAYED CYCLIC PEPTIDE LIBRARY AND METHODS OF MAKING THE SAME THE TEXAS A&M UNIVERSITY SYSTEM (US) 2023-05-04 US disclosed
EP-3972625-A1 A GENETICALLY ENCODED, PHAGE-DISPLAYED CYCLIC PEPTIDE LIBRARY AND METHODS OF MAKING THE SAME The Texas A&M University System (US) 2022-03-30 EP disclosed
CN-113727725-A Genetically encoded phage-displayed cyclic peptide libraries and methods of making the same 得克萨斯A&M大学系统 2021-11-30 CN disclosed
WO-2020236146-A1 A GENETICALLY ENCODED, PHAGE-DISPLAYED CYCLIC PEPTIDE LIBRARY AND METHODS OF MAKING THE SAME THE TEXAS A&M UNIVERSITY SYSTEM (US) 2020-11-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230139680-A1 A GENETICALLY ENCODED, PHAGE-DISPLAYED CYCLIC PEPTIDE LIBRARY AND METHODS OF MAKING THE SAME QPCTL, LNPEP, QPCT SLC7A5 1345/4885SLC1A3 696/4885SLC1A2 648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.